Clinical Trial Update: Noninvasive Biomarkers of Metabolic Liver Disease 1.1 [NA]

View source ↗

Summary

A completed clinical trial from Massachusetts General Hospital investigating noninvasive biomarkers for metabolic liver disease, including nonalcoholic steatohe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver | NA | Status: COMPLETED | Results posted: 2023-07-11